// App-Quantinova.ai

Tu1000 : Formal Hepatitis B (HBV) Education Improves Not Only Knowledge but Also Acceptance of Antiviral Therapy Among the HBV-Infected Vulnerable Patient Population

Researchers

Presenter

  • Colina Yim

Principal Investigators

  • Donna M. Evon

  • Mauricio Lisker-Melman

  • Harry Janssen

  • Mohamed Hassan

  • Coleman Smith

  • Anna S. Lok

  • Mandana Khalili

Medical Centers

  • Department of Internal Medicine, University of Michigan, Ann Arbor, MI

  • Diabetes Center, University of California San Francisco, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • University of North Carolina, Chapel Hill, NC

  • Newborn Medicine, Washington University, St. Louis, MO

  • Medicine, Univ of Toronto, Toronto, Canada

  • University of Minnesota, Minneapolis, MN

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hepatitis B

  • Liver cancer

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • Alanine transaminase

  • Hepatitis B surface antigen

  • Hepatitis B e antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved